This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human/Mouse BMPR-II Fc Chimera Protein, CF
catalog :
811-BR-100
quantity :
100 ug
price :
529 USD
citations: 11
Reference
Srole D, Jung G, Waring A, Nemeth E, Ganz T. Characterization of erythroferrone structural domains relevant to its iron-regulatory function. J Biol Chem. 2023;299:105374 pubmed publisher
Guo J, Liu B, Thorikay M, Yu M, Li X, Tong Z, et al. Crystal structures of BMPRII extracellular domain in binary and ternary receptor complexes with BMP10. Nat Commun. 2022;13:2395 pubmed publisher
Cate R, di Clemente N, Racine C, Groome N, Pepinsky R, Whitty A. The anti-Müllerian hormone prodomain is displaced from the hormone/prodomain complex upon bivalent binding to the hormone receptor. J Biol Chem. 2022;298:101429 pubmed publisher
Mang T, Kleinschmidt Doerr K, Ploeger F, Schoenemann A, Lindemann S, Gigout A. BMPR1A is necessary for chondrogenesis and osteogenesis, whereas BMPR1B prevents hypertrophic differentiation. J Cell Sci. 2020;133: pubmed publisher
Huang B, Yuan Y, Li T, Ding S, Zhang W, Gu Y, et al. Facilitated receptor-recognition and enhanced bioactivity of bone morphogenetic protein-2 on magnesium-substituted hydroxyapatite surface. Sci Rep. 2016;6:24323 pubmed publisher
Yoon B, Chung Y, Yoo S, Kawara K, Kim J, Yoo I, et al. Preferential Induction of the T Cell Auxiliary Signaling Molecule B7-H3 on Synovial Monocytes in Rheumatoid Arthritis. J Biol Chem. 2016;291:4048-57 pubmed publisher
Kienast Y, Jucknischke U, Scheiblich S, Thier M, de Wouters M, Haas A, et al. Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains. J Biol Chem. 2016;291:3395-410 pubmed publisher
Castonguay R, Werner E, Matthews R, Presman E, Mulivor A, Solban N, et al. Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. J Biol Chem. 2011;286:30034-46 pubmed publisher
Sengle G, Ono R, Lyons K, Bachinger H, Sakai L. A new model for growth factor activation: type II receptors compete with the prodomain for BMP-7. J Mol Biol. 2008;381:1025-39 pubmed publisher
Serpe M, Umulis D, Ralston A, Chen J, Olson D, Avanesov A, et al. The BMP-binding protein Crossveinless 2 is a short-range, concentration-dependent, biphasic modulator of BMP signaling in Drosophila. Dev Cell. 2008;14:940-53 pubmed publisher
Reversade B, De Robertis E. Regulation of ADMP and BMP2/4/7 at opposite embryonic poles generates a self-regulating morphogenetic field. Cell. 2005;123:1147-60 pubmed
product information
master code :
811-BR
SKU :
811-BR-100
product name :
Recombinant Human/Mouse BMPR-II Fc Chimera Protein, CF
unit size :
100 ug
description :
The Recombinant Human/Mouse BMPR-II Fc Chimera Protein, CF from R&D Systems is derived from NS0. The Recombinant Human/Mouse BMPR-II Fc Chimera Protein, CF has been validated for the following applications: Bioactivity.
target :
BMPR-II
category :
Proteins and Enzymes
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS.
conjugate :
Unconjugated
purity :
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
species :
Human, Mouse
observed molecular weight :
65-75 kDa, reducing conditions
theoretical molecular weight :
41.5 kDa (monomer)
gene symbol :
BMPR2
details of functionality :
Measured by its binding ability in a functional ELISA. When Recombinant Mouse GDF-9 (Catalog # 739-G9) is immobilized at 2 ╡g/mL (100 ╡L/well), the concentration of Recombinant Human/Mouse BMPR-II Fc Chimera that produces 50% of the optimal binding response is found to be approximately 0.1 - 0.5 ╡g/mL.
endotoxin note :
<0.10 EU per 1 ╡g of the protein by the LAL method.
accessionNumbers :
Q13873
applications :
Bioactivity
source long :
Mouse myeloma cell line, NS0-derived BMPR-II protein Human BMPR-II (Ala26 - Ile151, with an N-terminal Met) Accession # Q13873 IEGRMD Human IgG1 (Pro100 - Lys330) 6-His tag N-terminus C-terminus
source short :
NS0
USD :
529 USD
alt names :
BMP type II receptor, BMP type-2 receptor, BMPR2, BMPR-2, BMPR3, BMPRII, BMPR-IIprimary pulmonary hypertension 1, Bone morphogenetic protein receptor type II, bone morphogenetic protein receptor type-2, bone morphogenetic protein receptor, type II (serine/threonine kinase), BRK-3, EC 2.7.11, EC 2.7.11.30, FLJ41585, FLJ76945, PPH1BMR2, T-ALK, type II activin receptor-like kinase, type II receptor for bone morphogenetic protein-4
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.